Evidence map›Paper›PMID 40093889›Full record

ArticleTheranostics2025

Comparison of 5-aminolevulinic acid and MMP-14 targeted peptide probes in preclinical models of GBM.

Benjamin B Kasten, Tingting Dai, Ke Jiang, Jennifer Coleman Clements, Kaixiang Zhou, Carlos A Gallegos, Seth N Lee, Anna G Sorace, Hailey A Houson, Logan D Stone and 3 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Benjamin B KastenDepartment of Otolaryngology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Tingting DaiDepartments of Radiology and Chemistry, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA 94305, USA.
Ke JiangDepartments of Radiology and Chemistry, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jennifer Coleman ClementsDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Kaixiang ZhouDepartments of Radiology and Chemistry, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA 94305, USA.
Carlos A GallegosDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Seth N LeeDepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Anna G SoraceDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Hailey A HousonDepartment of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Logan D StoneDepartment of Otolaryngology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
James M MarkertDepartment of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Jianghong RaoDepartments of Radiology and Chemistry, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jason M WarramDepartment of Otolaryngology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMASP20CA151129 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GILLESPIE, G. YANCEY · 2011 to 2013
$2.3M
Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for gliomaR01CA279143 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JAMES M MARKERT, Anna C Sorace · 2023 to 2026
$2.3M
Training Program in Brain Tumor BiologyT32NS048039 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BENVENISTE, ETTY N · 2007 to 2017
$2.0M
Major upgrade for UAB Bruker BioSpec preclinical 9.4T MRIS10OD028498 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SORACE, ANNA C · 2020 to 2020
$601k
NCATS NIH HHS UL1 TR001417NCI NIH HHS P20 CA151129NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA279143NIH HHS S10 OD028498NINDS NIH HHS T32 NS048039
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aminolevulinic AcidBrain NeoplasmsGlioblastomaMatrix Metalloproteinase 14PeptidesAnimalsCell Line, TumorDisease Models, AnimalFemaleHumansMiceMice, NudeOptical ImagingPositron-Emission TomographyAminolevulinic AcidMatrix Metalloproteinase 14Peptides5-ALAGBMMMP-14NIRFPET

Identifiers

PMID40093889
PMCPMC11905129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.